Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse. - Wikidata - awgldk - TriplyDB

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

http://www.wikidata.org/entity/Q35558096

about

Detection of cancer before distant metastasis High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small cell lung cancer patients Very late relapse in breast cancer survivors: a report of 6 cases.Circulating tumor cells in non-metastatic triple-negative breast cancer.Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.Markers for the identification of late breast cancer recurrence.Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity Fine-needle aspirate CYFRA 21-1, an innovative new marker for diagnosis of axillary lymph node metastasis in breast cancer patients.Biomarkers characterization of circulating tumour cells in breast cancer patients The expression of CK-19 gene in circulating tumor cells of blood samples of metastatic breast cancer women.Assessment of Cytokeratin-19 Gene Expression in Peripheral Blood of Breast Cancer Patients and Breast Cancer Cell Lines.Tumour dormancy and clinical implications in breast cancer.Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.Gene expression markers in circulating tumor cells may predict bone metastasis and response to hormonal treatment in breast cancer.Recent advances and prospects in the isolation by size of epithelial tumor cells (ISET) methodology.Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.Circulating tumor cells as promising novel biomarkers in solid cancers.Gene expression profiling and DNA methylation analyses of CTCs.Establishment of a multimarker qPCR panel for the molecular characterization of circulating tumor cells in blood samples of metastatic breast cancer patients during the course of palliative treatment.Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC).Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.Classifying circulating tumor cells to monitor cancer progression.

P2860

Q30540711-18590D35-06BC-4EEA-B37E-D26198F503E2 Q33648891-54070B89-9485-4BA9-84A7-0CE8BC940AED Q34082366-14D41F16-A5EA-4550-B366-8566E91A7F9E Q34111867-28635FC0-038C-4E59-8C27-1B98DBCE6F0B Q35000713-B0EF14A1-2366-4B7C-9F28-62CE363E60B4 Q35018949-95E5AE8F-B2D1-40CB-B3BC-B1D62A7E9EAD Q35124176-96068845-53E0-48E0-9050-9F3558F4221D Q36151589-B42A71C1-44FA-4E1C-AEAD-C607BB03BA09 Q36245346-F113257D-9C7A-4180-9728-036538246E45 Q36423754-43B56F95-E5CF-46E9-AE6D-A687048C2A57 Q36856910-4FA26CAE-BC1A-44E5-B005-4FE220AFFA4A Q36863179-76D8FC5B-202F-407D-B82F-36DEAE4B2E70 Q36959162-C004BC38-0559-40BC-943C-F55A2EF2674B Q37560932-578AE6D9-D4E3-4413-AAEF-5FBAA1B73E4F Q38085411-AA0583A0-88AE-42F5-A2A8-8CB3E1708C51 Q38097525-74342F56-557D-4D33-800E-39076409E5B7 Q38196920-0BB7E8D6-32C7-4F65-983C-9C1AE9955ED2 Q38734877-51BEFEC3-A4CE-44F3-8364-7AA191948BC0 Q38862668-929FB09C-6758-49B9-97D1-F4B6081C21CD Q41047711-B2F75200-4414-4A64-9F79-8598C19FFB43 Q42372003-6DB73192-F293-4E4F-97DE-07B5E9BDA7B8 Q43685849-916C7BB3-3129-4338-98B0-0559A8233C41 Q53755908-8F466F40-0141-416E-9DE3-76E855871F36

P2860

Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse.

http://www.wikidata.org/entity/Q35558096

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Cytokeratin-19 mRNA-positive c ...... ic relevance for late relapse.

@ast

Cytokeratin-19 mRNA-positive c ...... ic relevance for late relapse.

@en

type

label

Cytokeratin-19 mRNA-positive c ...... ic relevance for late relapse.

@ast

Cytokeratin-19 mRNA-positive c ...... ic relevance for late relapse.

@en

prefLabel

Cytokeratin-19 mRNA-positive c ...... ic relevance for late relapse.

@ast

Cytokeratin-19 mRNA-positive c ...... ic relevance for late relapse.

@en

P1433

Q35558096-EA04FDC2-BC8C-4B5C-BA9D-71EFB038A545

P1476

Q35558096-69E62C75-3FFF-4912-BDE7-3F888738294A

P2093

Q35558096-0EA3117A-94D9-4E94-AC2E-29C5CA421ABB

Q35558096-2F1A1495-AC38-405F-8A61-F47BEE7C442E

Q35558096-3192D956-83BF-4DBB-AB75-B8800F9BC1E6

Q35558096-354E4268-A8D2-4997-8920-C5FBC2FA0DE7

Q35558096-4F84A11F-226C-4D28-898C-6A118ACA485E

Q35558096-5BD21324-06FC-4252-9C4D-22ED1CC35991

Q35558096-A93404CD-4768-4777-BCCC-C310889ACB8B

Q35558096-F3EC4C20-0B1E-46E7-9F28-7BAC9E0CA688

P2860

Q35558096-01537370-899C-46BA-B1A1-91EE3124693F

Q35558096-0751A541-5112-44C1-BF36-7738EF424A05

Q35558096-17CD53AD-AA82-470C-ABC7-FE30F665F947

Q35558096-3FD70258-B0FC-4DB8-8750-5CC39B96551A

Q35558096-4FF7ECF3-0B73-436E-91B1-B268A2A48A86

Q35558096-5C54D59E-326D-482F-B36F-4777C600A925

Q35558096-670606DB-5F3E-4297-B63C-4F86F32BA527

Q35558096-6F3CC7F4-2275-4304-BEDB-4DEDB111A512

Q35558096-87449C1E-D9AB-4E53-BCFC-19ADD8E79C84

Q35558096-95BA76D9-95D2-4456-B2E1-22EA50D87DBE

P2888

Q35558096-3FF1E986-185B-484D-8DCF-FDF86DED8CE2

P304

Q35558096-25EE3B2C-4642-4B5F-B4A7-AB0A97B5576C

P31

Q35558096-2F22B4B0-5FBB-4974-9461-1863157F5DB3

P356

Q35558096-DB82820F-CAA8-445B-9485-3FFDD74705F1

P407

Q35558096-834094EA-F8ED-4912-A9EB-8B27124B095C

P433

Q35558096-87B9DAE3-9071-468B-8F0B-E34368B78066

P478

Q35558096-79F29776-9616-4767-9FEF-61E072C4008C

P50

Q35558096-7F7A0028-2C6E-424A-9EE9-DF2873903033

Q35558096-C03D4A46-C35E-4568-B28C-BAD2138F3D27

P577

Q35558096-5D861783-5ABE-44E8-AA77-B81E9F8B6B6B

P5875

Q35558096-272F408A-019D-4832-A1A3-60764E34DA55

P6179

Q35558096-BF42101A-7DE7-442B-8B4F-25F23E6885B8

P698

Q35558096-15A89493-3012-43CC-9131-72ED5C4C6DF5

P932

Q35558096-FF291204-2670-4ED1-B8A1-6D85562AD301

P356

P1433

Breast Cancer Research

P1476

Cytokeratin-19 mRNA-positive c ...... tic relevance for late relapse

@en

P2093

Alexandros Xyrafas

http://www.w3.org/2001/XMLSchema#string

Antonia Kalykaki

http://www.w3.org/2001/XMLSchema#string

Dimitris Mavroudis

http://www.w3.org/2001/XMLSchema#string

Kostas Kalbakis

http://www.w3.org/2001/XMLSchema#string

Maria Perraki

http://www.w3.org/2001/XMLSchema#string

Sophia Agelaki

http://www.w3.org/2001/XMLSchema#string

Stella Apostolaki

http://www.w3.org/2001/XMLSchema#string

Vassilis Georgoulias

http://www.w3.org/2001/XMLSchema#string

P2860

Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis

Cancer statistics, 2010

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques.

Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells

Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse.

Detection and clinical importance of micrometastatic disease.

30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis.

P2888

P304

R60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2897

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Emmanouil Saloustros

Galatea Kallergi

P577

2011-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51210080

http://www.w3.org/2001/XMLSchema#string

P6179

1013519723

http://www.w3.org/2001/XMLSchema#string

P698

21663668

http://www.w3.org/2001/XMLSchema#string

P932

3218949

http://www.w3.org/2001/XMLSchema#string